Literature DB >> 21682965

Evaluation of the World Health Organization algorithm for the diagnosis of HIV-associated sputum smear-negative tuberculosis.

D Wilson1, L Mbhele, M Badri, C Morroni, J Nachega, R E Chaisson, G Maartens.   

Abstract

BACKGROUND: Outcomes from the World Health Organization's (WHO's) recommendations for the diagnosis of smear-negative tuberculosis (SNTB) in high human immunodeficiency virus prevalence settings are unknown.
METHODS: We retrospectively applied the WHO algorithm for SNTB without danger signs to a prospectively enrolled cohort of ambulatory adult SNTB suspects in KwaZulu-Natal, South Africa. Participants fulfilling specified criteria for SNTB started empiric anti-tuberculosis treatment; the rest of the cohort was observed. All were followed for 8 weeks. Confirmed TB was defined as positive culture or granulomata plus acid-fast bacilli on histology.
RESULTS: In total, 221 participants retrospectively fulfilled the WHO ambulatory SNTB algorithm entry criteria. The diagnostic performance of the WHO algorithm was: positive predictive value 0.34 (95%CI 0.26-0.43), negative predictive value 0.86 (95%CI 0.76-0.92), positive likelihood ratio 1.43 (95%CI 1.34-1.48), negative likelihood ratio 0.46 (95%CI 0.38-0.56) and diagnostic odds 3.1 (95%CI 1.52-6.34). Losses to follow-up (n = 4), hospitalisations (n = 6) and deaths (n = 5) did not differ significantly in those who were and were not diagnosed with SNTB.
CONCLUSIONS: The WHO ambulatory SNTB algorithm had a reasonably high negative predictive value but low positive predictive value. Mortality over an 8-week period was low in participants who met the entry criteria for the WHO algorithm.

Entities:  

Mesh:

Year:  2011        PMID: 21682965     DOI: 10.5588/ijtld.10.0440

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  13 in total

1.  Empiric TB Treatment of Severely Ill Patients With HIV and Presumed Pulmonary TB Improves Survival.

Authors:  Winceslaus Katagira; Nicholas D Walter; Saskia Den Boon; Nelson Kalema; Irene Ayakaka; Eric Vittinghoff; William Worodria; Adithya Cattamanchi; Laurence Huang; John Lucian Davis
Journal:  J Acquir Immune Defic Syndr       Date:  2016-07-01       Impact factor: 3.731

Review 2.  Diagnostic point-of-care tests in resource-limited settings.

Authors:  Paul K Drain; Emily P Hyle; Farzad Noubary; Kenneth A Freedberg; Douglas Wilson; William R Bishai; William Rodriguez; Ingrid V Bassett
Journal:  Lancet Infect Dis       Date:  2013-12-10       Impact factor: 25.071

3.  Antibodies against Mycobacterial proteins as biomarkers for HIV-associated smear-negative tuberculosis.

Authors:  Michael Siev; Douglas Wilson; Supreet Kainth; Victoria O Kasprowicz; Catherine M Feintuch; Elizabeth R Jenny-Avital; Jacqueline M Achkar
Journal:  Clin Vaccine Immunol       Date:  2014-03-26

4.  Comparison of two methods for acquisition of sputum samples for diagnosis of suspected tuberculosis in smear-negative or sputum-scarce people: a randomised controlled trial.

Authors:  Jonathan G Peter; Grant Theron; Anil Pooran; Johnson Thomas; Mellissa Pascoe; Keertan Dheda
Journal:  Lancet Respir Med       Date:  2013-07-19       Impact factor: 30.700

Review 5.  Research on implementation of interventions in tuberculosis control in low- and middle-income countries: a systematic review.

Authors:  Frank Cobelens; Sanne van Kampen; Eleanor Ochodo; Rifat Atun; Christian Lienhardt
Journal:  PLoS Med       Date:  2012-12-18       Impact factor: 11.069

6.  Validating a scoring system for the diagnosis of smear-negative pulmonary tuberculosis in HIV-infected adults.

Authors:  Isabella Coimbra; Magda Maruza; Maria de Fátima Pessoa Militão Albuquerque; Joanna D'Arc Lyra Batista; Maria Cynthia Braga; Líbia Vilela Moura; Demócrito Barros Miranda-Filho; Ulisses Ramos Montarroyos; Heloísa Ramos Lacerda; Laura Cunha Rodrigues; Ricardo Arraes de Alencar Ximenes
Journal:  PLoS One       Date:  2014-04-22       Impact factor: 3.240

7.  Can point-of-care urine LAM strip testing for tuberculosis add value to clinical decision making in hospitalised HIV-infected persons?

Authors:  Jonathan G Peter; Grant Theron; Keertan Dheda
Journal:  PLoS One       Date:  2013-02-04       Impact factor: 3.240

8.  Performance of the 2007 WHO algorithm to diagnose smear-negative pulmonary tuberculosis in a HIV prevalent setting.

Authors:  Helena Huerga; Francis Varaine; Eric Okwaro; Mathieu Bastard; Elisa Ardizzoni; Joseph Sitienei; Jeremiah Chakaya; Maryline Bonnet
Journal:  PLoS One       Date:  2012-12-19       Impact factor: 3.240

9.  Predictors for MTB Culture-Positivity among HIV-Infected Smear-Negative Presumptive Tuberculosis Patients in Uganda: Application of New Tuberculosis Diagnostic Technology.

Authors:  Lydia Nakiyingi; Bareng A S Nonyane; Willy Ssengooba; Bruce J Kirenga; Damalie Nakanjako; Gloria Lubega; Pauline Byakika-Kibwika; Moses L Joloba; Jerry J Ellner; Susan E Dorman; Harriet Mayanja-Kizza; Yukari C Manabe
Journal:  PLoS One       Date:  2015-07-29       Impact factor: 3.240

10.  Impact of HIV-associated conditions on mortality in people commencing anti-retroviral therapy in resource limited settings.

Authors:  Catherine S Marshall; Andrea J Curtis; Tim Spelman; Daniel P O'Brien; Jane Greig; Leslie Shanks; Philipp du Cros; Esther C Casas; Marcio Silveira da Fonseca; Eugene Athan; Julian H Elliott
Journal:  PLoS One       Date:  2013-07-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.